Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is frequently associated with type 2 diabetes. However, there is no specific medical therapy to treat this condition. Angiotensin‐converting enzyme 2 (ACE2) of the protective renin angiotensin system gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajapaksha, Indu G., Gunarathne, Lakmie S., Asadi, Khashayar, Laybutt, Ross, Andrikopoulous, Sof, Alexander, Ian E., Watt, Mathew J., Angus, Peter W., Herath, Chandana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035567/
https://www.ncbi.nlm.nih.gov/pubmed/34951153
http://dx.doi.org/10.1002/hep4.1884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035567/
https://www.ncbi.nlm.nih.gov/pubmed/34951153
http://dx.doi.org/10.1002/hep4.1884

Ejemplares similares